Federal reviewers found that 103 of 351 examined cases — nearly 30% — contained "concerning features" at Network for Hope, formerly known as Kentucky Organ Donor Affiliates before a 2023 merger, the organ procurement organization serving Kentucky and parts of Indiana, Ohio and West Virginia, according to HHS. That finding is now the basis for one of the most consequential regulatory actions in the history of the U.S. transplant system: on August 5, the Centers for Medicare & Medicaid Services issued a formal decertification notice against the organization, stripping it of the federal designation it needs to operate.

The decertification, only the second of its kind ever issued against an organ procurement organization (OPO), marks a rare instance of Washington moving to shut down a component of the transplant pipeline rather than simply fining or monitoring it. It also lands squarely in the health policy conversation at a moment when trust in institutional oversight is already under scrutiny across the health system, from hospital billing to insurance denials.

What investigators found

The case against Network for Hope, traces back to a whistleblower account describing a 2021 incident in which an overdose patient began regaining consciousness while staff were preparing to recover his organs, according to CNN. The man survived, and the procurement was halted, but the episode triggered a congressional inquiry led by the House Energy and Commerce Committee that ran for more than a year.

That inquiry led the Health Resources and Services Administration to reopen an investigation that the Biden administration had previously closed without action. HRSA reviewed 351 cases from 2021 through 2024 in which organ donation had been authorized by a family but never completed. Of those, 103 showed "concerning features," and 73 patients displayed neurological signs that HHS says were incompatible with organ donation, according to Healthcare Dive. Regulators went further, concluding that at least 28 patients may not have been deceased at the time the organ procurement process began.

The findings, according to HHS, pointed to a pattern rather than isolated errors: inconsistent neurological assessments, poor coordination between OPO staff and hospital medical teams, questionable handling of family consent, and misclassification of causes of death, particularly in overdose cases. A subsequent CMS review completed in May identified continuing problems with donor evaluations, adverse-event tracking and internal administration, indicating the organization had not resolved the issues after being placed under a corrective action plan the year before.

A "bad apple," according to Kennedy

HHS Secretary Robert F. Kennedy Jr. announced the decertification in person in Lexington, Kentucky, calling Network for Hope a "bad apple" and framing the action as necessary to preserve public confidence in a donation system that depends entirely on voluntary participation. "When an organization entrusted with the gift of life repeatedly puts patients at risk, the federal government has the duty to act," Kennedy said, according to CNN. HRSA Administrator Thomas Engels added that "despite intensive oversight, ongoing monitoring by the OPTN and repeated opportunities for improvement, significant patient safety concerns remained."

The decertification is the second brought under Kennedy's tenure targeting an OPO under congressional scrutiny; HHS decertified the Life Alliance Organ Recovery Agency in Miami last September over similar allegations of fraud and patient-safety lapses, according to a House committee memo. Together, the two actions signal a broader push by HHS to use decertification, rather than lighter-touch corrective action plans, as its primary enforcement tool for chronic OPO performance problems — a marked shift from prior practice, where the roughly 55 OPOs nationwide had rarely faced existential regulatory consequences regardless of performance metrics.

Congressional overseers who spearheaded the investigation welcomed the move. House Energy and Commerce Committee Chairman Brett Guthrie of Kentucky said the decision "takes a step forward in restoring integrity" to the transplant system, while Oversight and Investigations Subcommittee Chairman John Joyce credited the finding to the panel's "rigorous oversight," according to a committee statement.

Network for Hope pushes back

Network for Hope disputes the findings and says it will appeal. CEO Barry Massa said in a statement that the organization "strongly disagrees" with the decision and remains compliant with Organ Procurement and Transplantation Network policy, pointing to a "pause in procedure" protocol it says it helped design and that has since been codified into Kentucky law, requiring recovery teams to halt any procedure if signs of life reemerge, according to USA Today. Massa also warned that the decision would jeopardize outcomes for more than 3,000 patients on transplant waiting lists tied to the organization's service area, though he separately said none of the 188 hospitals the group serves are expected to see disruption — an apparent inconsistency the organization did not clarify.

Under federal rules, Network for Hope has 15 business days to request reconsideration of the decision and can pursue a formal hearing if CMS upholds it. The termination of its Medicare agreement is not scheduled to take effect until November 3, and its service territory cannot be reassigned to a competing OPO until the appeals process concludes or the organization drops its challenge, according to the CMS notice. CMS has signaled it may temporarily extend the current agreement to avoid a coverage gap during the transition.

Why this matters beyond Kentucky

The case lands at a sensitive moment for the national transplant system, which has faced years of scrutiny over uneven OPO performance and limited public accountability. Roughly 100,000 Americans are on transplant waiting lists at any given time, and every regional OPO holds an effective monopoly over organ recovery in its designated area, meaning failures cannot easily be offset by competition the way they might in other health care markets. Hospital partners in the affected region, including UC Health in Cincinnati, have said they do not currently expect disruptions to transplant services and are confident in continuity of care during the transition, according to Cincinnati.com.

For health system leaders and policymakers, the decertification raises a harder question that will likely outlast the Network for Hope case itself: whether CMS's newly demonstrated willingness to pull OPO certifications, rather than rely on corrective action plans and monitoring agreements, will become the new normal for an industry that has operated for decades with minimal direct federal consequence for underperformance. If the appeal fails and Network for Hope's territory is reassigned this fall, it would be the clearest test yet of whether the country's organ donation infrastructure can absorb a wholesale operator transition without harming the patients and families it depends on to sustain donation rates nationally.